Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 19;27(1):53.
doi: 10.1186/1756-9966-27-53.

NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues

Ibrahim Meteoglu  1 , Ibrahim H Erdogdu, Nezih Meydan, Muhan Erkus, Sabri Barutca
Affiliations

NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues

Ibrahim Meteoglu et al. J Exp Clin Cancer Res. .

Abstract

Background: Clear cell renal cell carcinoma (ccRCC) is the most frequently encountered tumor in the adult kidney. Many factors are known to take part in the development and progression of this tumor. Nuclear factor kappa B (NF-kappaB) is a family of the genes that includes five members acting in events such as inflammation and apoptosis. In this study, the role of NF-kappaB (p50 subunit) in ccRCC and its relation to angiogenesis and apoptosis were investigated.

Methods: Formalin-fixed and paraffin embedded tissue blocks from 40 patients with ccRCC were studied. Expressions of NF-kappaB (p50), VEGF, EGFR, bc1-2 and p53 were detected immunohistochemically. The relationship of NF-kappaB with these markers and clinicopathological findings were evaluated.

Results: The expression of NF-kappaB was detected in 35 (85%), VEGF in 37 (92.5%), EGFR in 38 (95%), bc1-2 in 33 (82.5%) and p53 in 13 (32.5%) of 40 ccRCC patients. Statistical analyses revealed a significant relation between NF-kappaB expression and VEGF (p = 0.001), EGFR (p = 0.004), bc1-2 (p = 0.010) and p53 (p = 0.037). There was no significant correlation between NF-kappaB and such parameters as tumor grade, stage, age and sex.

Conclusion: The results of this study indicated that in ccRCC cases NF-kappaB was associated with markers of angiogenesis and apoptosis such as VEGF, EGFR, bc1-2 and p53. In addition, the results did not only suggest a close relationship between NF-kappaB and VEGF, EGFR, bc1-2 and p53 in ccRCC, but also indicate that NF-kappaB was a potential therapeutic target in the treatment of ccRCC resistant to chemotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strong immunostaining for markers in ccRCC. Expression of NF-κB in malignant and non-malignant renal tissue (A), high-level immunstaining for NF-κB (B), VEGF (C), EGFR (D), bcl-2 (E), and p53 (F). Note that increased NF-κB expression is associated with increased VEGF, EGFR, bcl-2 and p53.
Figure 2
Figure 2
Weak positive immunostaining for markers in ccRCC. Expression of NF-κB in malignant and non-malignant renal tissue (A), low degree of immunostaning for NF-κB (B), VEGF (C), EGFR (D), bcl-2 (E), and p53 (F).
See this image and copyright information in PMC

References

    1. Jemal A, Murray T, Ward E. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
    1. Godley P, Kim SW. Renal cell carcinoma. Curr Opin Oncol. 2002;14:280–5. doi: 10.1097/00001622-200205000-00005. - DOI - PubMed
    1. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680–6684. doi: 10.1038/sj.onc.1209954. - DOI - PubMed
    1. Bonizzi G, Karin M. The two NF-KappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280–288. doi: 10.1016/j.it.2004.03.008. - DOI - PubMed
    1. Baldwin AS. Control of carcinogenesis and cancer therapy resistance by the transcription factor NF-Kappa B. J Clin Invest. 2001;107:241–246. doi: 10.1172/JCI11991. - DOI - PMC - PubMed

Publication types

MeSH terms